Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis.
Koo
J Y
JY
Psoriasis and Skin Treatment Center, University of California San Francisco, 94143, USA. jymkoo@orca.ucsf.edu
Martin
D
D
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000209:etiology; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005782:Gels; D006801:Humans; D008297:Male; D008875:Middle Aged; D000068656:Mometasone Furoate; D009539:Nicotinic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D009824:Ointments; D011244:Pregnadienediols / Q000009:adverse effects / Q000627:therapeutic use*; D011537:Pruritus / Q000139:chemically induced; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000187:drug effects / Q000473:pathology; D016896:Treatment Outcome; D012176:Retinoids
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D005782:Gels; D000068656:Mometasone Furoate; D009539:Nicotinic Acids; D009824:Ointments; D011244:Pregnadienediols; C086827:tazarotene; D012176:Retinoids